Trials / Completed
CompletedNCT05423574
Robotic Trans-Abdominal Retromuscular Umbilical Prosthesis (r-TARUP)
Feasibility Study of Robotic Trans-Abdominal Retromuscular Umbilical Prosthesis (r-TARUP) for the Treatment of Primary and Incisional Ventral Hernia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Combining the advantage of minimally invasive surgery with laparoscopy to reduce postoperative complications and the placement of a retromuscular prosthesis with closure of the defect in order to reduce the risk of adhesion and restore normal anatomy in the treatment of primary and incisional ventral hernias, is made possible through robotic assistance. The challenge of this study concerns the evaluation of quality of life, postoperative pain and recurrence at 6 months in the management of primary and incisional ventral hernias by robot-assisted laparoscopic approach.
Detailed description
The robotic-assisted laparoscopic approach for the treatment of primary and secondary ventral hernias is already used in the visceral department of Nancy in France. This technique seems to reduce post operative pain, to improve quality of live and to reduce recurrence. The goal of the study is to evaluate the benefices of this technique. The quality of life, postoperative pain and recurrence will be evaluated at one and six months postoperatively. The recurrence will be evaluated by clinical examination and a computed tomography scan performed at sixth month postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | robotic Trans Abdomino Pre Peritoneal prothesis repair | The treatment of primary and incisional ventral hernia using the robotic assisted laparoscopy technique |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2021-07-01
- Completion
- 2022-03-01
- First posted
- 2022-06-21
- Last updated
- 2022-06-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05423574. Inclusion in this directory is not an endorsement.